Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Diamantopoulos P, Koumbi D, Kotsianidis I, Pappa V, Symeonidis A, Galanopoulos A, Zikos P, Papadaki HA, Panayiotidis P, Dimou M, Hatzimichael E, Vassilopoulos G, Delimpasis S, Mparmparousi D, Papageorgiou S, Variami E, Kyrtsonis MC, Megalakaki A, Kotsopoulou M, Repousis P, Adamopoulos I, Kontopidou F, Christoulas D, Kourakli A, Tsokanas D, Konstantinos Papoutselis M, Kyriakakis G, Viniou NA; Hellenic MDS study group. Diamantopoulos P, et al. Among authors: galanopoulos a. Cancer Med. 2019 May;8(5):2056-2063. doi: 10.1002/cam4.2090. Epub 2019 Mar 21. Cancer Med. 2019. PMID: 30897290 Free PMC article.
Treatment of patients with myelodysplastic syndrome with amifostine.
Galanopoulos A, Kritikou-Griva E, Gligori J, Michalis E, Grigoraki V, Marinakis T, Kakkas J, Tasiopoulou A, Anagnostopoulos NI. Galanopoulos A, et al. Leuk Res. 2001 Aug;25(8):665-71. doi: 10.1016/s0145-2126(01)00004-2. Leuk Res. 2001. PMID: 11397471 Clinical Trial.
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Viniou N, Terpos E, Galanopoulos A, Kritikou-Griva E, Akel S, Michalis E, Apostolidou E, Georgiadou D, Kouraklis A, Parharidou A, Kokkini G, Symeonidis A, Anagnostopoulos NI, Christakis JI, Tasiopoulou A, Loukopoulos D, Yataganas X. Viniou N, et al. Among authors: galanopoulos a. Ann Hematol. 2002 Apr;81(4):182-6. doi: 10.1007/s00277-002-0442-y. Epub 2002 Mar 27. Ann Hematol. 2002. PMID: 11976818 Clinical Trial.
FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study.
Lilakos K, Viniou NA, Mavrogianni D, Vassilakopoulos TP, Dimopoulou MN, Plata E, Angelopoulou MK, Variami E, Stavrogianni N, Liapi D, Xilouri I, Galanopoulos A, Ageloudi M, Panayiotidis P, Voulgarelis M, Rombos J, Meletis J, Yataganas X, Pangalis GA. Lilakos K, et al. Among authors: galanopoulos a. Anticancer Res. 2006 Mar-Apr;26(2A):1201-7. Anticancer Res. 2006. PMID: 16619525 Free article.
Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
Galanopoulos AG, Symeonidis A, Kourakli A, Papadaki EA, Tsaftaridis P, Terpos E, Aktipi A, Roussou P, Protopappa M, Pappaioannou M, Zikos P, Speletas M, Parcharidou A, Laoutaris N, Anagnostopoulos NI, Meletis J, Pangalis GA, Zoumbos N, Viniou N; Hellenic MDS Study Group. Galanopoulos AG, et al. Eur J Haematol. 2007 Jan;78(1):89-90. doi: 10.1111/j.1600-0609.2006.00764.x. Eur J Haematol. 2007. PMID: 17302860 No abstract available.
Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.
Ximeri M, Galanopoulos A, Klaus M, Parcharidou A, Giannikou K, Psyllaki M, Symeonidis A, Pappa V, Kartasis Z, Liapi D, Hatzimichael E, Kokoris S, Korkolopoulou P, Sambani C, Pontikoglou C, Papadaki HA; Hellenic MDS Study Group. Ximeri M, et al. Among authors: galanopoulos a. Haematologica. 2010 Mar;95(3):406-14. doi: 10.3324/haematol.2009.010876. Epub 2009 Sep 22. Haematologica. 2010. PMID: 19773257 Free PMC article.
Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor.
Diamantopoulos PT, Chatzileonida T, Galanopoulos A, Yiakoumis X, Saridaki AM, Angelidis A, Papakostas E, Bazanis E, Sachanas S, Michael M, Pangalis GA, Anagnostopoulos NI, Meletis J, Viniou NA. Diamantopoulos PT, et al. Among authors: galanopoulos a. Leuk Lymphoma. 2012 Oct;53(10):2069-72. doi: 10.3109/10428194.2012.668679. Epub 2012 Apr 9. Leuk Lymphoma. 2012. PMID: 22360720 No abstract available.
Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
Papadopoulou V, Diamantopoulos PT, Kontandreopoulou E, Polonyfi K, Variami E, Kouzis P, Galanopoulos A, Spanakis N, Zervakis K, Iliakis T, Perrea D, Kollia P, Vassilakopoulos TP, Pangalis GA, Kyrtsonis C, Vaiopoulos G, Viniou NA. Papadopoulou V, et al. Among authors: galanopoulos a. Leuk Lymphoma. 2014 Aug;55(8):1904-9. doi: 10.3109/10428194.2013.867487. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24261679
Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.
Miltiades P, Lamprianidou E, Vassilakopoulos TP, Papageorgiou SG, Galanopoulos AG, Vakalopoulou S, Garypidou V, Papaioannou M, Hadjiharissi E, Pappa V, Papadaki HA, Spanoudakis E, Tsatalas K, Kotsianidis I. Miltiades P, et al. Among authors: galanopoulos ag. Blood Cancer J. 2014 Feb 28;4(2):e187. doi: 10.1038/bcj.2014.9. Blood Cancer J. 2014. PMID: 24583533 Free PMC article. No abstract available.
107 results